Perrigo Company PLC
$ 10.86
2.45%
10 Apr - close price
- Market Cap 1,459,083,000 USD
- Current Price $ 10.86
- High / Low $ 10.98 / 10.66
- Stock P/E N/A
- Book Value 21.33
- EPS -10.12
- Next Earning Report 2026-05-06
- Dividend Per Share $1.16
- Dividend Yield 10.7 %
- Next Dividend Date -
- ROA 0.02 %
- ROE -0.39 %
- 52 Week High 26.88
- 52 Week Low 9.23
About
Perrigo Company plc is an American Irish registered manufacturer of private label over-the-counter pharmaceuticals.
Analyst Target Price
$17.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-26 | 2025-11-05 | 2025-08-06 | 2025-05-02 | 2025-02-27 | 2024-11-06 | 2024-08-02 | 2024-05-07 | 2024-02-27 | 2023-11-07 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0.77 | 0.8 | 0.57 | 0.6 | 0.36 | 0.81 | 0.53 | 0.29 | 0.86 | 0.64 | 0.63 | 0.45 |
| Estimated EPS | 0.8133 | 0.76 | 0.59 | 0.5658 | 0.95 | 0.83 | 0.46 | 0.23 | 0.83 | 0.63 | 0.51 | 0.42 |
| Surprise | -0.0433 | 0.04 | -0.02 | 0.0342 | -0.59 | -0.02 | 0.07 | 0.06 | 0.03 | 0.01 | 0.12 | 0.03 |
| Surprise Percentage | -5.324% | 5.2632% | -3.3898% | 6.0445% | -62.1053% | -2.4096% | 15.2174% | 26.087% | 3.6145% | 1.5873% | 23.5294% | 7.1429% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.41 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Jan 1970 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-24 | 2025-12-16 | None | 2025-06-17 | 2025-03-25 | 2024-12-17 | 2024-09-17 | 2024-06-18 | 2024-03-26 | 2023-12-19 |
| Amount | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.276 | $0.276 | $0.276 | $0.276 | $0.273 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PRGO
2026-04-10 17:29:00
Perrigo Co. PLC (PRGO) saw its stock advance by 2.45% on a challenging trading day, closing at $10.86. This performance put it ahead of the S&P 500 Index and the Dow Jones Industrial Average, which both experienced declines. Despite the daily gain, the company's stock remains significantly below its 52-week high.
2026-04-09 18:08:50
Dimensional Fund Advisors has filed an amended Schedule 13G/A, disclosing a passive stake of 6,567,616 shares in Perrigo Co PLC, representing 4.8% of the common stock. Dimensional holds sole voting power over 6,451,767 shares and sole dispositive power over all 6,567,616 shares. The filing clarifies that these shares are owned by various Funds managed or advised by Dimensional, which disclaims beneficial ownership, indicating a portfolio-management holding rather than an activist stake.
2026-04-09 17:29:00
Perrigo Co. PLC's stock (PRGO) fell by 2.12% to $10.60 on Thursday, despite a generally favorable trading session for the broader stock market, with the S&P 500 and Dow Jones Industrial Average both rising. The company's stock closed significantly below its 52-week high, underperforming its competitors.
2026-04-08 17:27:00
Perrigo Co. PLC (PRGO) stock rose 2.56% to $10.83 on Wednesday, outperforming the broader market which also saw significant gains. This increase broke a three-day losing streak for the company's shares.
2026-04-08 06:10:52
The article provides a financial overview of Perrigo Company PLC (PRGO), detailing its revenue breakdown, profitability, and competitor comparison within the Pharmaceuticals industry. The company's largest revenue contributor is Upper Respiratory at 17.4% ($182.00M), and it reports a gross margin of 32.64%, operating margin of 7.61%, and a negative net margin of -127.49%. PRGO, with a market capitalization of $1.49B, is benchmarked against competitors like BHVN and DMRA.
2026-04-08 05:09:49
This article provides a precision trading analysis for Perrigo Company Plc (PRGO), highlighting near- and mid-term strong sentiment but a weak long-term outlook. It details specific trading strategies, including long, breakout, and short positions, with corresponding entry zones, targets, and stop losses. The analysis also features multi-timeframe signal analysis and an exceptional risk-reward setup.
